Respiratory Infections


  • Scientists See New Hope in Fight Against HIV and TB
    As U.S. policymakers consider scaling back on its historic initiative to fight AIDS around the world and downsizing goals to combat tuberculosis, next-generation treatment and prevention strategies to significantly reduce the spread of HIV/AIDS and tuberculosis are now ...More
    May 20, 2010
    Posted in News
  • Progress in the Tuberculosis Drug Development Pipeline
    According to a paper published today in The Lancet, there is unprecedented progress in the development of the global tuberculosis (TB) drug pipeline with 10 drug candidates currently in clinical development. The paper was written by a team of renowned international experts ...More
    May 19, 2010
    Posted in News
  • ICU Infection Rates Not a Good Measure of Mortality Risk
    ICU-acquired infection rates are not an indication of patients’ mortality risk, according to researchers the University of Pennsylvania, undermining a central tenet of many pay-for-performance initiatives. Public reporting of quality data is increasingly common in ...More
    May 17, 2010
    Posted in News
  • New Technique May Quickly Distinguish Between Active and Latent TB
    An emerging technique designed to quickly distinguish between people with active and dormant tuberculosis may help health professionals diagnose the disease sooner, thereby potentially limiting early exposure to the disease, according to a study conducted by researchers at ...More
    May 17, 2010
    Posted in News
  • False Positives in TB Diagnosis Lead to Real Negatives for HIV Patients
    HIV-infected patients who are falsely diagnosed as having tuberculosis (TB) have higher rates of mortality than those who are correctly diagnosed with the disease, according to a study conducted by researchers at University of California-San Francisco and Makerere ...More
    May 17, 2010
    Posted in News
  • Researchers Discover Metabolic Vulnerability in TB and Potential Drug Target
    Tuberculosis (TB) has been present in humans since ancient times. The origins of the disease date back to the first domestication of cattle, and skeletal remains show prehistoric humans (4,000 B.C.) had TB. Although relatively rare in the United States, it is the single ...More
    May 11, 2010
    Posted in News
  • New Avenues for Overcoming Tuberculosis Drug Resistance
    Tuberculosis (TB) continues to be a global health problem, in part due to the exceptional drug resistance displayed by the TB-causing agent, Mycobacterium tuberculosis. Beyond even acquired drug resistance, these bacteria are also inherently resistant to many other common ...More
    April 27, 2010
    Posted in News
  • Aerosols: A New Tool Against TB?
    Scientists have developed a new strategy for treating tuberculosis using dry powder aerosols that could be delivered with an inhaler. The researchers from the University of North Carolina School of Pharmacy, Chapel Hill, North Carolina; and Harvard School of Engineering and ...More
    April 15, 2010
    Posted in News
  • Vaccine Has Led to Changes in Pneumococcal Infections
    In the decade since the introduction of pneumococcal vaccination, significant shifts have occurred in the bacterial strains causing serious pneumococcal infections in children, according to a pair of studies in the April issue of the Pediatric Infectious Disease Journal. ...More
    April 12, 2010
    Posted in News
  • Public/Private Partnerships Essential to Expand TB Detection and Treatment
    Top multinational business and nonprofit leaders concluded that private sector core competencies are essential to help curb the spread of tuberculosis (TB) — a treatable disease ravaging the developing world. These competencies can be leveraged by:-- Forging ...More
    March 29, 2010
    Posted in News